Drug affinity complex is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2025-09-19. Numbers and descriptions here follow the published literature rather than marketing material.
The albumin-binding version stays in circulation for days, because covalent attachment to serum albumin shields the peptide from rapid filtration and degradation. Reported half-lives for this form fall in the range of several days. The version without the linker is cleared in minutes, with estimates often near thirty minutes in animal work. These figures come from small studies and vary with assay method, species, and route, so they are best read as approximate rather than fixed constants.
Studies in this area generally track growth hormone pulses, insulin-like growth factor 1 concentrations, and occasionally body composition endpoints. Most published human data come from early, small trials, and questions about long-term effects remain open. Whether repeated exposure alters pituitary responsiveness over time is not settled. Analytical work relies on immunoassays for the hormones and on mass spectrometry for the peptide itself, because the two measurements answer different questions.
Binding of the peptide to the growth hormone-releasing hormone receptor on pituitary somatotrophs triggers a G protein coupled cascade that raises cyclic AMP and opens calcium channels. The result is greater secretion of growth hormone into the bloodstream. Because the peptide acts at the same receptor as the natural hypothalamic hormone, its effect is amplified pulse size rather than an entirely separate release pathway. Receptor binding alone does not determine the response, since somatostatin tone and other inputs modulate the final output.
CJC-1295 is a synthetic peptide designed as a long-acting analogue of growth hormone-releasing hormone (GHRH). Its structure derives from the first 29 amino acids of native GHRH, a fragment often called GRF(1-29). Four substitutions were introduced to slow enzymatic breakdown and extend activity relative to the natural sequence. The compound was developed by ConjuChem as part of a broader effort to improve the pharmacokinetic profile of peptide hormones. It is studied in laboratory and clinical research settings rather than appearing as a naturally occurring substance.
Two related forms circulate in technical discussion under the same family name. The original version carries a drug affinity complex (DAC) that binds covalently to serum albumin after administration, and this linkage substantially extends circulation time. A second form, frequently written as modified GRF(1-29) or CJC-1295 without DAC, lacks that linker and clears much faster. The naming is a frequent source of confusion because the shorthand CJC-1295 can refer to either form depending on the source. Reports sometimes fail to specify which variant was studied.
The peptide backbone includes a D-alanine at position two, which resists cleavage by dipeptidyl peptidase IV, and several other substitutions that reduce degradation. Its molecular weight is roughly 3.4 kDa without the linker and about 3.6 kDa with it. The molecule is water soluble and is normally supplied as a lyophilized powder. Precise sequence and mass values depend on which variant is described, so technical documents usually state the exact form being referenced.
| Property | Value | Notes |
|---|---|---|
| Target receptor | GHRH receptor (GHRHR) | Expressed on pituitary somatotrophs |
| Primary action | Stimulates growth hormone release | Amplifies pulse size |
| Half-life, albumin-binding form | Several days as reported | Slow release from albumin complex |
| Half-life, unmodified analog | About 30 minutes in animal estimates | Cleared by proteases and filtration |
| Common analytical approach | LC-MS/MS for peptide, immunoassay for hormones | Methods answer different questions |
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone, built on the 29-amino-acid GHRH(1-29) fragment. Four substitutions distinguish it from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes reduce enzymatic cleavage and extend the peptide's persistence in circulation. The compound is discussed in two forms, one carrying a drug affinity complex and one without it.
The drug affinity complex is a maleimidopropionic acid group attached to a lysine side chain. It reacts with the free thiol of cysteine-34 on circulating albumin, forming a covalent bond. This conjugation keeps the peptide in the bloodstream and shields it from rapid renal filtration and proteolysis. Reported circulation half-lives for the albumin-bound form fall in the range of roughly six to nine days in early human studies.
Binding to GHRH receptors on pituitary somatotroph cells triggers cyclic AMP signaling and stimulates growth hormone synthesis and release. Because the peptide acts upstream of the pituitary, effects are mediated through endogenous growth hormone rather than direct receptor activation in peripheral tissues. Increases in insulin-like growth factor 1 are generally described as a downstream consequence. Most published human exposure data come from small early-stage studies, and the clinical significance of the pharmacokinetic profile remains incompletely characterized.
CJC-1295 acts at the growth hormone-releasing hormone receptor, a G-protein-coupled receptor found on somatotroph cells in the anterior pituitary. Binding triggers a rise in cyclic AMP and calcium entry, which promotes release of stored growth hormone. Because the peptide mimics the body's own releasing hormone, it amplifies existing secretory pulses rather than driving continuous output. The size of the response therefore depends partly on the subject's own hormonal rhythm and feedback state.
The attached maleimide group explains the unusual duration of the DAC version. After injection it reacts with the thiol of cysteine-34 on serum albumin, forming a stable covalent bond. The resulting conjugate is too large for rapid kidney filtration and is shielded from many peptidases. Reported half-lives for this form reach several days, whereas the version without the group is cleared in roughly half an hour. That gap is the main pharmacological difference between the two.
CJC-1295 belongs to a class of synthetic peptides modeled on growth hormone releasing hormone, a forty-four amino acid signal produced by the hypothalamus. The compound is built from the first twenty-nine residues of the natural sequence, with four substitutions introduced at positions 2, 8, 15 and 27. These changes were designed to slow enzymatic breakdown while preserving receptor activation. The result is a peptide that is shorter than native GHRH and considerably more resistant to ordinary clearance pathways in circulation.
Two related forms appear under the CJC-1295 name. The simpler analogue, commonly written as modified GRF(1-29), carries the four substitutions but no additional conjugation. The second form attaches a maleimidopropionic acid linker to a lysine residue, a modification frequently called the drug affinity complex. That linker reacts with the free thiol on serum albumin to form a covalent bond. Because albumin has a long residence time in blood, the conjugated peptide stays in circulation far longer than the unconjugated analogue.
John Davison Rockefeller III (March 21, 1906 – July 10, 1978) was an American philanthropist. Rockefeller was the eldest son and second child of John D. Rockefeller Jr. and Abby Aldrich Rockefeller as well as a grandson of Standard Oil co-founder John D. Rockefeller. He was engaged in a wide range of philanthropic projects, many of which his family had launched, as well as supporting organizations related to East Asian affairs. Rockefeller was also a major supporter of the Population Council, and the committee that created the Lincoln Center in Manhattan.
=== Cited texts === Borror DJ, Triplehorn CA, Delong DM (1989). Introduction to the Study of Insects (6th ed.). Saunders College Publishing. ISBN 978-0-03-025397-3. Hölldobler B, Wilson EO (1990). The Ants. Harvard University Press. ISBN 978-0-674-04075-5.
While the revolutions in the Austrian territories had been suppressed by 1849, in Hungary, the situation was more severe and Austrian defeat seemed imminent. Sensing a need to secure his right to rule, Franz Joseph sought help from Russia, requesting the intervention of Tsar Nicholas I, in order "to prevent the Hungarian insurrection developing into a European calamity". For the Russian military support, Franz Joseph kissed the hand of the tsar in Warsaw on 21 May 1849. Tsar Nicholas supported Franz Joseph in the name of the Holy Alliance, and sent a 200,000 strong army with 80,000 auxiliary forces led by General Ivan Paskevich. Finally, the joint army of Russian and Austrian forces defeated the Hungarian forces. After the restoration of Habsburg power, Hungary was placed under brutal martial law. This led to the death of Lajos Batthyány and executions in Arad. With order now restored throughout his empire, Franz Joseph felt free to renege on the constitutional concessions he had made, especially as the Austrian parliament meeting at Kremsier had behaved—in the young Emperor's eyes—abominably. The 1849 constitution was suspended, and a policy of absolutist centralism was established, guided by the Minister of the Interior, Alexander Bach.
Sources: en.wikipedia.org
(a) Maintain records that detail the nature and value of transactions, whether such transactions comprise a single transaction or a series of connected transactions, and where these transactions take place within a month. (b) Furnish information on transactions referred to in clause (a) to the Director within the time prescribed, including records of the identity of all its clients. Section 12 (2) prescribes that the records referred to in sub-section (1) as mentioned above, must be maintained for ten years after the transactions finished. It is handled by the Indian Income Tax Department. The provisions of the Act are frequently reviewed and various amendments have been passed from time to time. Most money laundering activities in India are through political parties, corporate companies and the share market. These are investigated by the Enforcement Directorate and Indian Income Tax Department. According to Government of India, out of the total tax arrears of ₹2,480 billion (US$26 billion) about ₹1,300 billion (US$13 billion) pertain to money laundering and securities scam cases. Bank accountants must record all transactions over Rs. 1 million and maintain such records for 10 years. Banks must also make cash transaction reports (CTRs) and suspicious transaction reports over Rs. 1 million within 7 days of initial suspicion. They must submit their reports to the Enforcement Directorate and Income Tax Department.
== Research == Gene therapy is currently being studied as a possible treatment for chronic granulomatous disease. CGD is well-suited for gene therapy since it is caused by a mutation in single gene which only affects one body system (the hematopoietic system). Viruses have been used to deliver a normal gp91 gene to rats with a mutation in this gene, and subsequently the phagocytes in these rats were able to produce oxygen radicals. In 2006, two human patients with X-linked chronic granulomatous disease underwent gene therapy and blood cell precursor stem cell transplantation to their bone marrow. Both patients recovered from their CGD, clearing pre-existing infections and demonstrating increased oxidase activity in their neutrophils. However, long-term complications and efficacy of this therapy were unknown. In 2012, a 16-year-old boy with CGD was treated at the Great Ormond Street Hospital, London with an experimental gene therapy that temporarily reversed the CGD and allowed him to overcome a life-threatening lung disease. In 2024, Prime Medicine began a Phase 1/2 open-label clinical trial to evaluate PM359, an investigational gene therapy, in patients with CGD caused by NCF1 mutations. The treatment involves transplantation of autologous CD34+ stem cells modified by prime editing ex vivo. Following an announcement of preliminary results in May 2025, Prime Medicine and its clinical collaborators reported in December 2025 that two CGD patients treated with PM359 had been "effectively cured" of the disease.
Team Fortress 2 is a multiplayer team-based first-person shooter that was first available as part of The Orange Box as one of its three original new games. The game is a sequel to the original Quake modification, Team Fortress, and Valve's Half-Life modification, Team Fortress Classic. Its focus is on two competing teams that attack each other in order to achieve varying objectives, including capturing control points or defending them from attack, or capturing a flag. Players can choose to play as one of nine classes in these teams, each with different strengths and weaknesses. Unlike most other Source-powered games, Team Fortress 2 features a cartoon art style and non-realistic graphics. Team Fortress 2 was very well received by critics; it was particularly praised for its unique artistic direction and graphics. In June 2011, the Steam version of Team Fortress 2 became free-to-play.
Sources: en.wikipedia.org
=== Mitosis === Yet another major aspect of cellular behavior that is thought to include rho protein signaling is mitosis. While rho GTPase activity was thought for years to be restricted to actin polymerization and therefore to cytokinesis, which occurs after mitosis, new evidence has arisen that shows some activity in microtubule formation and the process of mitosis itself. This topic is still debated, and there is evidence both for and against for the importance of rho in mitosis.
=== Regulation by CRISPRi === Recent genome-wide CRISPR interference (CRISPRi) screens have identified genes whose selective inhibition modulates specific components of the SASP during inflammation-induced senescence, such as that triggered by interleukin-6 (IL-6). These approaches have helped distinguish molecular regulators of replicative senescence from those involved in inflammatory senescence, providing new targets for studying aging-related pathways. SASP has been reduced through inhibition of p38 mitogen-activated protein kinases and janus kinase. The protein hnRNP A1 (heterogeneous nuclear ribonucleoprotein A1) antagonizes cellular senescence and induction of the SASP by stabilizing Oct-4 and sirtuin 1 mRNAs.
A woman sentenced to 28 months imprisonment for illegally obtaining abortion pills in 2020 has her sentence reduced to a 14-month suspended sentence by the Court of Appeal, and will be released from prison. The Home Office confirms the release of the first passports issued in King Charles III's name. 19 July The UK rate of inflation falls from 8.7% in May to 7.9% in June. Rishi Sunak issues an apology for the UK's historical treatment of LGBT people who were dismissed from the military because of their sexuality. 20 July Senior doctors begin a two-day walkout, their first strike in a decade, amid an ongoing dispute over pay. The Competition and Markets Authority tells supermarkets they must make their food pricing clearer in order to help shoppers make informed decisions about the best deals. A University of Oxford study suggests that if heavy meat eaters were to cut some of it out of their diet it would be like removing eight million cars from the road. The first phase of the COVID-19 Inquiry comes to an end, with an interim report expected to be published in 2024. 21 July July 2023 by-elections: Uxbridge and South Ruislip: The former seat of ex-PM Boris Johnson is held by the Conservatives, but with a significantly reduced majority of 495 votes. The proposed ULEZ expansion by Labour's Sadiq Khan, Mayor of London, is a factor in the result. Selby and Ainsty: Labour takes the formerly safe Conservative seat of Selby and Ainsty. The swing of 23.7% is the largest since 1945.
Sources: en.wikipedia.org
Reported values cluster in the range of several days, reflecting slow release from the albumin complex. Estimates differ across species and assay platforms. The figure describes circulation time in study settings rather than a fixed property.
Typical endpoints include growth hormone pulse frequency and amplitude, together with insulin-like growth factor 1 concentration. Some protocols add body composition or metabolic markers. Interpretation depends on baseline hormonal status, which varies widely between individuals.
Most human data come from small, early-stage studies, and independent replication is limited. Short-term effects on growth hormone release are documented; longer-term outcomes are not well characterized. Open questions include changes in pituitary responsiveness after repeated exposure.
No. It is a synthetic analogue modeled on the first 29 residues of human GHRH. The substitutions and any linker are laboratory modifications rather than features of the endogenous peptide.